Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD
Launched by ADINA MAEIR · Nov 22, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to support Ultra-Orthodox Jewish mothers who have children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). The aim is to see if this program can help these mothers manage stress, learn more about ADHD, and improve their overall well-being. The study will look at whether mothers can easily join the program, if it helps them understand ADHD better and feel less stigma around it, and if it encourages them to take better care of themselves.
To participate, mothers need to have a child between the ages of 6 and 12 who has been diagnosed with ADHD by a qualified doctor. They will attend six weekly online group sessions with other mothers, complete some questionnaires before and after the program, and give feedback in a discussion group. Additionally, experienced educators from the community will also provide input to help improve the program. This study is currently recruiting participants, and it offers a chance for mothers to connect, learn, and support each other in a culturally sensitive environment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • mothers of children with ADHD aged 6- 12 years old
- • Mothers who identify as ultra-orthodox Jews
- • Child diagnosis was by a licensed medical professional
- Exclusion Criteria:
- • Child medical diagnosis other than ADHD
About Adina Maeir
Adina Maeir is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous scientific research and development. Committed to enhancing patient outcomes, Adina Maeir collaborates with leading healthcare professionals and organizations to conduct high-quality clinical trials across various therapeutic areas. With a strong emphasis on ethical practices and regulatory compliance, the organization aims to contribute to the global medical community by accelerating the delivery of safe and effective treatments to patients in need. Their expertise in trial design, patient engagement, and data integrity positions them as a trusted partner in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Adina Maeir, PhD
Principal Investigator
Hebrew University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported